Y Cheng, R Shen, F Liu, Y Li, J Wang, Y Hou, Y Liu… - Vaccine, 2024 - Elsevier
Investigating the mechanisms by which W135 meningococcal conjugate (PSW135-TT) activates adaptive immune responses in mice can provide a comprehensive understanding …
Activation of B cells and T cells requires the engagement of costimulatory signaling pathways in addition to Ag receptor signaling for efficient immune responses. None of the …
A Donadei, C Balocchi, F Mancini, D Proietti… - European Journal of …, 2016 - Elsevier
Conjugation of a small molecule immunopotentiator to antigens has been proposed to deliver the ligand to the receptor, localize its action and minimize systemic inflammation …
KR Alugupalli - Frontiers in Immunology, 2024 - frontiersin.org
None of the typhoid Vi Polysaccharide (ViPS) subunit vaccines incorporate adjuvants, and the immunogenicity of ViPS vaccines (eg Typbar TCV® and Typhim Vi®) is in part due to …
WH Chen, S Basu, AK Bhattacharjee… - Innate …, 2010 - journals.sagepub.com
When given passively or elicited actively, antibodies induced by a detoxified Escherichia coli Rc chemotype (J5) mutant lipopolysaccharide (J5dLPS)—group B meningococcal outer …
JP Phipps, KM Haas - The Journal of Infectious Diseases, 2019 - academic.oup.com
Protection against encapsulated bacteria can be elicited using polysaccharide vaccines. These antigens often behave as T-cell–independent type 2 antigens (TI-2 Ags). However, TI …
Z Lai, JR Schreiber - Clinical and Vaccine Immunology, 2011 - Am Soc Microbiol
Bacterial polysaccharides (PS) are T cell-independent antigens that do not induce immunologic memory and are poor immunogens in infants. Conjugate vaccines in which the …
T Zhang, W Yu, Y Wang, T Hu - Vaccine, 2015 - Elsevier
Neisseria meningitidis can cause severe and fulminant diseases such as meningitis. Meningococcal capsular polysaccharide (PS) is a key virulence determinant that is not able …
R Kensinger, AB Arunachalam - Glycoconjugate Journal, 2022 - Springer
Bacterial capsular polysaccharide vaccines are generally poorly immunogenic in infants and older adults. The immunogenicity of capsular polysaccharide vaccines can be improved by …